Each year in Japan there are between 20-30 reported incidences of death from hymenoptera stings. The most prevalent cause of death is anaphylaxis, so that rapid diagnosis and treatment are necessary. We retrospectively examined clinical records of 400 cases with hymenoptera stings, who consulted our two hospitals in Northeastern Iwate Prefecture (Saiseikai Iwaizumi Hospital, and Emergency Critical Care Center, Iwate Prefectural Kuji Hospital) between January 2004 and December 2004. The 400 cases comprised 231 males and 169 females, and the average age was 51.2 years old (ranging from 0-92 years old). The incidence of stings was higher from July to September, and many victims were in their 50's to 70's. Most of the stinger attacks were in their upper extremities, and 323 patients experienced a single sting in each case. Others experienced more than two stings each. Fifteen cases had been transported by ambulance, and one case resulted in death. There were 31 cases (7.6%) with systemic reaction, and 14 cases (3.5%) with severe systemic reaction (dyspnea, hypotension, collapse, etc). None of the patients in the study had used Epipen
® (epinephrine self-injection carrying kit) before arriving at hospital. On the average, anaphylaxis appears from within a few minutes to 15 minutes. Yet for 23 cases examined, it took 79 minutes on the average before reaching the hospital, which greatly exceeds the time before anaphylaxis occurs. The conditions of the patients were worsened probably because they didn't have Epipen
®, which could have been used effectively before the onset of anaphylaxis. The Epipen
® was put on the market in Japan in August 2003, and can be used before the patient arrives at hospital. In preventing death due to anaphylaxis of hymenoptera stings, it is necessary to make Epipen
® known and available to those persons living in potentially affected regions.
View full abstract